GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Accounts Payable

NeuBase Therapeutics (STU:O7P) Accounts Payable : €0.24 Mil (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is NeuBase Therapeutics Accounts Payable?

NeuBase Therapeutics's Accounts Payable for the quarter that ended in Sep. 2023 was €0.24 Mil.

NeuBase Therapeutics's quarterly Accounts Payable declined from Mar. 2023 (€0.55 Mil) to Jun. 2023 (€0.30 Mil) and declined from Jun. 2023 (€0.30 Mil) to Sep. 2023 (€0.24 Mil).

NeuBase Therapeutics's annual Accounts Payable declined from Sep. 2019 (€1.34 Mil) to Sep. 2020 (€1.28 Mil) but then increased from Sep. 2020 (€1.28 Mil) to Sep. 2021 (€1.54 Mil).


NeuBase Therapeutics Accounts Payable Historical Data

The historical data trend for NeuBase Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuBase Therapeutics Accounts Payable Chart

NeuBase Therapeutics Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 1.34 1.28 1.54

NeuBase Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 0.35 0.55 0.30 0.24

NeuBase Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


NeuBase Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of NeuBase Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


NeuBase Therapeutics (STU:O7P) Business Description

Traded in Other Exchanges
Address
350 Technology Drive, Suite 421, Pittsburgh, PA, USA, 15219
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

NeuBase Therapeutics (STU:O7P) Headlines

No Headlines